Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hormones and Bone Tissue

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

The Parathyroid Glands

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comprehensive genomic analysis of adrenocortical carcinoma reveals genetic profiles associated with patient survival.

ESMO open·2024

Same author

Choice of control tissue impacts designation of germline variants in a cohort of papillary thyroid carcinoma patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Same author

Parathyroid, Thyroid and Recurrent Laryngeal Nerve Anatomy in an Indian Rhinoceros (Rhinoceros unicornis).

World journal of surgery·2017

Same author

Genetics of adrenocortical tumours.

Journal of internal medicine·2016

Same author

Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016

Same author

Human achaete-scute homolog-1 is highly expressed in a subset of neuroendocrine tumors.

Oncology reports·2011

Search research articles

Related Experiment Video

Updated: Jul 22, 2026

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation

Published on: March 14, 2017

Parathyroid surgery in familial hyperparathyroid disorders.

T Carling¹, R Udelsman

¹Department of Surgery, Yale University School of Medicine, New Haven, CT, USA.

Journal of Internal Medicine

|December 21, 2004

Summary

Managing familial hyperparathyroidism (HPT) requires tailored surgical approaches for specific genetic syndromes to ensure long-term normocalcemia and minimize complications. Surgical principles focus on preserving parathyroid function and facilitating future interventions for recurrent disease.

More Related Videos

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Related Experiment Videos

Last Updated: Jul 22, 2026

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation

Published on: March 14, 2017

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Area of Science:

Endocrinology
Surgical Oncology
Genetics

Background:

Familial hyperparathyroidism (HPT) presents complex management challenges due to genetic predispositions to persistent or recurrent disease.
Specific syndromes like Multiple Endocrine Neoplasia (MEN1, MEN2A), familial isolated HPT, and HPT-Jaw Tumor (HPT-JT) syndrome require distinct surgical strategies.
Underlying genetic mutations, such as in the calcium-sensing receptor (CASR) gene, influence surgical considerations and outcomes.

Purpose of the Study:

To outline the surgical management principles for various familial hyperparathyroidism syndromes.
To emphasize the importance of achieving and maintaining normocalcemia while avoiding complications.
To discuss the applicability of minimally invasive techniques in familial HPT.

Main Methods:

Surgical strategies including subtotal parathyroidectomy, total parathyroidectomy with autotransplantation, and radical subtotal parathyroidectomy are discussed.
Intraoperative parathyroid hormone (PTH) monitoring is highlighted as a tool to guide surgical resection.
Bilateral cervical exploration is presented as the standard approach, with consideration for minimally invasive parathyroidectomy (MIP) in select cases.

Main Results:

Different familial HPT syndromes necessitate specific surgical techniques, such as parathyroidectomy for MEN2A and familial isolated HPT, and careful attention to cancer risk in HPT-JT.
Radical subtotal parathyroidectomy is indicated for familial HPT with CASR gene mutations.
Intraoperative PTH measurements aid in optimizing parathyroid resection, especially in multiglandular disease.

Conclusions:

Surgical management of familial HPT must be individualized based on the specific genetic syndrome.
The goals of surgery are long-term normocalcemia, prevention of hypocalcemia and complications, and enabling future interventions.
While bilateral exploration is common, MIP may be feasible for a subset of familial HPT patients.